CARCINOSIN CORD (Energique, Inc.)
Welcome to the PulseAid listing for the CARCINOSIN CORD drug offered from Energique, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Energique, Inc. |
| NON-PROPRIETARY NAME: | Carcinosin |
| SUBSTANCE NAME: | HUMAN BREAST TUMOR CELL |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2015-07-09 |
| END MARKETING DATE: | 0000-00-00 |
CARCINOSIN CORD HUMAN OTC DRUG Details:
| Item Description | CARCINOSIN CORD from Energique, Inc. |
| LABELER NAME: | Energique, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12([hp_X]/mL) |
| START MARKETING DATE: | 2015-07-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 44911-0191_00a3ca4d-a739-411c-b0a7-5eccd2d1934e |
| PRODUCT NDC: | 44911-0191 |
| APPLICATION NUMBER: | |
Other HUMAN BREAST TUMOR CELL Pharmaceutical Manufacturers / Labelers:
